These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3290060)

  • 1. Geriatric rheumatology: safe use of potentially toxic antirheumatics.
    Melnyk V
    Geriatrics; 1988 Jul; 43(7):83-7, 90. PubMed ID: 3290060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational agents for rheumatoid arthritis.
    Merkel PA; Letourneau EN; Polisson RP
    Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
    Mariani L; Baratelli M
    Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease-modifying agents and immunosuppressive drugs in the elderly.
    O'Callaghan JW; Brooks PM
    Clin Rheum Dis; 1986 Apr; 12(1):275-89. PubMed ID: 2872995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow-acting antirheumatic drugs and immunosuppressives.
    Baillieres Clin Rheumatol; 1990 Dec; 4(3):405-704. PubMed ID: 2093436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic approach to elderly patients with rheumatoid arthritis].
    Beccerica E
    Clin Ter; 1987 Aug; 122(4):289-98. PubMed ID: 2973390
    [No Abstract]   [Full Text] [Related]  

  • 7. Antirheumatic agents: CNS toxicity and its avoidance.
    Iobst WF; Bridges CR; Regan-Smith MG
    Geriatrics; 1989 Apr; 44(4):95, 99-100, 102. PubMed ID: 2647590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dosage and adverse effects of commonly used antirheumatic agents].
    Mathies H
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):320-6. PubMed ID: 5317064
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adverse effects of antirheumatics in children and adolescents].
    Hoza J; Rubín A; Fink Z; Havelka S
    Cesk Pediatr; 1984 Sep; 39(9):536-9. PubMed ID: 6334566
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive therapy with cytostatic agents in rheumatology].
    Borrachero del Campo J
    Rev Esp Reum Enferm Osteoartic; 1969 Oct; 13(4):204-14. PubMed ID: 4937879
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antirheumatics. 40].
    Mayr E
    Pharm Prax; 1969 Dec; 12():265-7 concl. PubMed ID: 4909744
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining the toxicity of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Furst DE
    J Rheumatol; 1991 Feb; 18(2):159-60. PubMed ID: 2023208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of pharmacotherapy of rheumatic diseases in advanced age].
    Breithaupt H
    Z Rheumatol; 1992; 51(6):301-4. PubMed ID: 1481580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of action of antirheumatic agents.
    Mathies H
    Triangle; 1979; 18(2-3):63-73. PubMed ID: 44578
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical pharmacology of nonsteroidal anti-inflammatory agents. III: Principles of therapeutic use].
    Reinicke C
    Z Arztl Fortbild (Jena); 1985; 79(12):515-22. PubMed ID: 3929483
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-inflammatory drugs in rheumatic diseases.
    Cosh JA
    Practitioner; 1974 Oct; 213(1276 SPEC NO):519-26. PubMed ID: 4376236
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
    Louyot P; Tamisier JN; Pourel J
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1428-31. PubMed ID: 4614820
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
    de Sèze S; Dryll A; Dreiser R
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1425-8. PubMed ID: 4614819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
    Anić B; Cikes N
    Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety issues related to DMARD therapy.
    Fries JF
    J Rheumatol Suppl; 1990 Nov; 25():14-7. PubMed ID: 2273518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.